Share with others who have ER-/PR-/HER2- breast cancer.
Posted on: Oct 3, 2019 09:51AM
Adding Keytruda to Chemotherapy Before Surgery for Early-Stage, Triple-Negative Breast Cancer Improves Response to Treatment
October 2, 2019
The combination of the immunotherapy Keytruda and chemotherapy before surgery to remove early-stage, triple-negative breast cancer led to a better pathologic complete response than chemotherapy alone. Read more...